A phase 1 study of efatutazone, an oral peroxisome proliferator‐activated receptor gamma agonist, administered to patients with advanced malignancies
Pishvaian, Michael J., Marshall, John L., Wagner, Andrew J., Hwang, Jimmy J., Malik, Shakun, Cotarla, Ion, Deeken, John F., He, A. Ruth, Daniel, Hirut, Halim, Abdel‐Baset, Zahir, Hamim, Copigneaux, Catherine, Liu, Kejian, Beckman, Robert A., Demetri, George D.
Published in Cancer (01.11.2012)
Published in Cancer (01.11.2012)
Get full text
Journal Article